1.61 -0.01 (-0.60%)
TTHI
| Trade TTHI now with |
Stock Details
Last Trade:1.61 Change:-0.01 (-0.60%) Prev Close:1.62 Open: 1.66 Days Range:1.60 – 1.68 52 Week Range: 1.15 - 5.49 Volume:49464 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 6:04pm
Trading Radar for 02/09: Sirius XM (SIRI), PepsiCo (PEP), Expedia (EXPE), Dunkin' Brands (DNKN), Linkedin (LNKD), Activision (ATVI) Report
Trading Radar for 02/09: Sirius XM (SIRI), PepsiCo (PEP), Expedia (EXPE), Dunkin' Brands (DNKN), Linkedin (LNKD), Activision (ATVI) Report
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before The Market Opens Economic: 8:30am ESTInitial Claims - Street sees 370K Continuing Claims - Street sees 3475KEarnings: API... Read More
Recent Alert on 12/12/11 at 6:59am
Transition Therapeutics (TTHI) Promotes Nicole Rusaw-George to CFO
Transition Therapeutics (TTHI) Promotes Nicole Rusaw-George to CFO
Recent Alert on 12/12/11 at 6:35am
Transition Therapeutics (TTHI) Doses First Patient in TT-401 Phase 1
Transition Therapeutics (TTHI) Doses First Patient in TT-401 Phase 1
Recent Alert on 12/12/11 at 6:35am
Transition Therapeutics (TTHI) Doses First Patient in TT-401 Phase 1
Transition Therapeutics (TTHI) Doses First Patient in TT-401 Phase 1
View AllRecent Press Releases
Press Release on 02/07/12 at 11:00am
Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2012 Financial Results on Thursday, February 9th, at 4:30 P.M. EST
Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2012 Financial Results on Thursday, February 9th, at 4:30 P.M. EST
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/20/11 at 4:08am
Transition Therapeutics: Early Stage Play for a Well Diversified Biotech Portfolio
Transition Therapeutics: Early Stage Play for a Well Diversified Biotech Portfolio
Blog Posts on 12/16/09 at 10:48am
Report from Europe: Stocks Recovering After Data Points to Dovish Fed
Report from Europe: Stocks Recovering After Data Points to Dovish Fed


